Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With Nivolumab
2018-01-01 Cimini, N.; Napoleoni, L.; Cortellini, A.; Parisi, A.; Pavese, F.; Orazio, C. D.; Verna, L.; Porzio, G.; Ficorella, C.
Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy
2018-01-01 Cortellini, A.; Palumbo, P.; Porzio, G.; Verna, L.; Giordano, A. V.; Masciocchi, C.; Parisi, A.; Cannita, K.; Ficorella, C.; Bozzetti, F.
Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A “snapshot” from clinical practice
2018-01-01 Cortellini, A.; Gambale, E.; Cannita, K.; Brocco, D.; Parisi, A.; Napoleoni, L.; Masedu, F.; Irtelli, L.; De Tursi, M.; Natoli, C.; Ficorella, C.
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study
2019-01-01 Parisi, A.; Cortellini, A.; Roberto, M.; Venditti, O.; Santini, D.; Dell'Aquila, E.; Stellato, M.; Marchetti, P.; Occhipinti, M. A.; Zoratto, F.; Mazzuca, F.; Tinari, N.; De Tursi, M.; Iezzi, L.; Natoli, C.; Ratti, M.; Pizzo, C.; Ghidini, M.; Porzio, G.; Ficorella, C.; Cannita, K.
Topical menthol for treatment of chemotherapy-induced peripheral neuropathy
2017-01-01 Cortellini, A.; Verna, L.; Cannita, K.; Napoleoni, L.; Parisi, A.; Ficorella, C.; Porzio, G.
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice
2018-01-01 Cortellini, A.; Cocciolone, V.; Irelli, A.; Pavese, F.; Sidoni, T.; Parisi, A.; Baldi, P. L.; Venditti, O.; D'Orazio, C.; Bonfili, P.; Franzese, P.; Zugaro, L.; Verna, L.; Porzio, G.; Santini, D.; Cannita, K.; Ficorella, C.
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: An update from clinical practice
2019-01-01 Cortellini, A.; Cannita, K.; Parisi, A.; Baldi, P. L.; Venditti, O.; D'Orazio, C.; Dal Mas, A.; Calvisi, G.; Giordano, A. V.; Vicentini, V.; Vicentini, R.; Felicioni, L.; Marchetti, A.; Buttitta, F.; Russo, A.; Ficorella, C.
Timed-flat infusion of 5-fluorouracil with docetaxel and oxaliplatin as first-line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen
2018-01-01 Cortellini, A.; Cannita, K.; Parisi, A.; Venditti, O.; Baldi, P. L.; De Berardis, B.; Vicentini, R.; Vicentini, V.; Verna, L.; Porzio, G.; Ficorella, C.
The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study
2019-01-01 Cortellini, A.; Porzio, G.; Masel, E. K.; Berghoff, A. S.; Knotzer, B.; Parisi, A.; Pavese, F.; Ficorella, C.; Verna, L.
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group
2013-01-01 Van De Loosdrecht, A. A.; Ireland, R.; Kern, W.; Della Porta, M. G.; Alhan, C.; Balleisen, J. S.; Bettelheim, P.; Bowen, D. T.; Burbury, K.; Eidenschink, L.; Cazzola, M.; Chu, S. S. C.; Cullen, M.; Cutler, J. A.; Drager, A. M.; Feuillard, J.; Fenaux, P.; Font, P.; Germing, U.; Haase, D.; Hellstrom-Lindberg, E.; Johansson, U.; Kordasti, S.; Loken, M. R.; Malcovati, L.; Te Marvelde, J. G.; Matarraz, S.; Milne, T.; Moshaver, B.; Mufti, G. J.; Nikolova, V.; Ogata, K.; Oelschlaegel, U.; Orfao, A.; Ossenkoppele, G. J.; Porwit, A.; Platzbecker, U.; Preijers, F.; Psarra, K.; Richards, S. J.; Subira, D.; Seymour, J. F.; Tindell, V.; Vallespi, T.; Valent, P.; Van Der Velden, V. H. J.; Wells, D. A.; De Witte, T. M.; Zettl, F.; Bene, M. C.; Westers, T. M.
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4 + T cells in a subset of cultures
2009-01-01 Ingram, W.; Kordasti, S.; Chan, L.; Barber, L. D.; Tye, G. J.; Hardwick, N.; Mufti, G. J.; Farzaneh, F.
JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells
2015-01-01 Keohane, C.; Kordasti, S.; Seidl, T.; Perez Abellan, P.; Thomas, N. S. B.; Harrison, C. N.; Mclornan, D. P.; Mufti, G. J.
IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome
2009-01-01 Kordasti, S. Y.; Afzali, B.; Lim, Z.; Ingram, W.; Hayden, J.; Barber, L.; Matthews, K.; Chelliah, R.; Guinn, B.; Lombardi, G.; Farzaneh, F.; Mufti, G. J.
Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group
2012-01-01 Westers, T. M.; Ireland, R.; Kern, W.; Alhan, C.; Balleisen, J. S.; Bettelheim, P.; Burbury, K.; Cullen, M.; Cutler, J. A.; Della Porta, M. G.; Drager, A. M.; Feuillard, J.; Font, P.; Germing, U.; Haase, D.; Johansson, U.; Kordasti, S.; Loken, M. R.; Malcovati, L.; Te Marvelde, J. G.; Matarraz, S.; Milne, T.; Moshaver, B.; Mufti, G. J.; Ogata, K.; Orfao, A.; Porwit, A.; Psarra, K.; Richards, S. J.; Subira, D.; Tindell, V.; Vallespi, T.; Valent, P.; Van Der Velden, V. H. J.; De Witte, T. M.; Wells, D. A.; Zettl, F.; Bene, M. C.; Van De Loosdrecht, A. A.
Neoantigens in MDS Are Associated with Two Novel CD4+T Cell Subsets and Improved Overall Survival
2017-01-01 Coats, T; Smith, Ae; Mourikis, A; Shahin, T; Kulasekararaj, Ag; Best, S; Chitre, S; Ellis, R; Petrov, N; Heck, S; Irish, Jm; Kordasti, S; Mufti, G
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome
2016-01-01 Kittang, A. O.; Kordasti, S.; Sand, K. E.; Costantini, B.; Kramer, A. M.; Perezabellan, P.; Seidl, T.; Rye, K. P.; Hagen, K. M.; Kulasekararaj, A.; Bruserud, O.; Mufti, G. J.
Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation
2016-01-01 Ceesay, M. M.; Kordasti, S.; Rufaie, E.; Lea, N.; Smith, M.; Wade, J.; Douiri, A.; Mufti, G. J.; Pagliuca, A.
Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation
2013-01-01 Afzali, B.; Edozie, F. C.; Fazekasova, H.; Scotta, C.; Mitchell, P. J.; Canavan, J. B.; Kordasti, S. Y.; Chana, P. S.; Ellis, R.; Lord, G. M.; John, S.; Hilton, R.; Lechler, R. I.; Lombardi, G.
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS)
2007-01-01 Kordasti, S. Y.; Ingram, W.; Hayden, J.; Darling, D.; Barber, L.; Afzali, B.; Lombardi, G.; Wlodarski, M. W.; Maciejewski, J. P.; Farzaneh, F.; Mufti, G. J.
Dendritic cells in myelodysplastic syndromes: From pathogenesis to immunotherapy
2013-01-01 Kerkhoff, N.; Bontkes, H. J.; Westers, T. M.; De Gruijl, T. D.; Kordasti, S.; Van De Loosdrecht, A. A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With Nivolumab | 1-gen-2018 | Cimini, N.; Napoleoni, L.; Cortellini, A.; Parisi, A.; Pavese, F.; Orazio, C. D.; Verna, L.; Porzio, G.; Ficorella, C. | |
| Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy | 1-gen-2018 | Cortellini, A.; Palumbo, P.; Porzio, G.; Verna, L.; Giordano, A. V.; Masciocchi, C.; Parisi, A.; Cannita, K.; Ficorella, C.; Bozzetti, F. | |
| Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A “snapshot” from clinical practice | 1-gen-2018 | Cortellini, A.; Gambale, E.; Cannita, K.; Brocco, D.; Parisi, A.; Napoleoni, L.; Masedu, F.; Irtelli, L.; De Tursi, M.; Natoli, C.; Ficorella, C. | |
| Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study | 1-gen-2019 | Parisi, A.; Cortellini, A.; Roberto, M.; Venditti, O.; Santini, D.; Dell'Aquila, E.; Stellato, M.; Marchetti, P.; Occhipinti, M. A.; Zoratto, F.; Mazzuca, F.; Tinari, N.; De Tursi, M.; Iezzi, L.; Natoli, C.; Ratti, M.; Pizzo, C.; Ghidini, M.; Porzio, G.; Ficorella, C.; Cannita, K. | |
| Topical menthol for treatment of chemotherapy-induced peripheral neuropathy | 1-gen-2017 | Cortellini, A.; Verna, L.; Cannita, K.; Napoleoni, L.; Parisi, A.; Ficorella, C.; Porzio, G. | |
| The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice | 1-gen-2018 | Cortellini, A.; Cocciolone, V.; Irelli, A.; Pavese, F.; Sidoni, T.; Parisi, A.; Baldi, P. L.; Venditti, O.; D'Orazio, C.; Bonfili, P.; Franzese, P.; Zugaro, L.; Verna, L.; Porzio, G.; Santini, D.; Cannita, K.; Ficorella, C. | |
| Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: An update from clinical practice | 1-gen-2019 | Cortellini, A.; Cannita, K.; Parisi, A.; Baldi, P. L.; Venditti, O.; D'Orazio, C.; Dal Mas, A.; Calvisi, G.; Giordano, A. V.; Vicentini, V.; Vicentini, R.; Felicioni, L.; Marchetti, A.; Buttitta, F.; Russo, A.; Ficorella, C. | |
| Timed-flat infusion of 5-fluorouracil with docetaxel and oxaliplatin as first-line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen | 1-gen-2018 | Cortellini, A.; Cannita, K.; Parisi, A.; Venditti, O.; Baldi, P. L.; De Berardis, B.; Vicentini, R.; Vicentini, V.; Verna, L.; Porzio, G.; Ficorella, C. | |
| The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study | 1-gen-2019 | Cortellini, A.; Porzio, G.; Masel, E. K.; Berghoff, A. S.; Knotzer, B.; Parisi, A.; Pavese, F.; Ficorella, C.; Verna, L. | |
| Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group | 1-gen-2013 | Van De Loosdrecht, A. A.; Ireland, R.; Kern, W.; Della Porta, M. G.; Alhan, C.; Balleisen, J. S.; Bettelheim, P.; Bowen, D. T.; Burbury, K.; Eidenschink, L.; Cazzola, M.; Chu, S. S. C.; Cullen, M.; Cutler, J. A.; Drager, A. M.; Feuillard, J.; Fenaux, P.; Font, P.; Germing, U.; Haase, D.; Hellstrom-Lindberg, E.; Johansson, U.; Kordasti, S.; Loken, M. R.; Malcovati, L.; Te Marvelde, J. G.; Matarraz, S.; Milne, T.; Moshaver, B.; Mufti, G. J.; Nikolova, V.; Ogata, K.; Oelschlaegel, U.; Orfao, A.; Ossenkoppele, G. J.; Porwit, A.; Platzbecker, U.; Preijers, F.; Psarra, K.; Richards, S. J.; Subira, D.; Seymour, J. F.; Tindell, V.; Vallespi, T.; Valent, P.; Van Der Velden, V. H. J.; Wells, D. A.; De Witte, T. M.; Zettl, F.; Bene, M. C.; Westers, T. M. | |
| Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4 + T cells in a subset of cultures | 1-gen-2009 | Ingram, W.; Kordasti, S.; Chan, L.; Barber, L. D.; Tye, G. J.; Hardwick, N.; Mufti, G. J.; Farzaneh, F. | |
| JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells | 1-gen-2015 | Keohane, C.; Kordasti, S.; Seidl, T.; Perez Abellan, P.; Thomas, N. S. B.; Harrison, C. N.; Mclornan, D. P.; Mufti, G. J. | |
| IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome | 1-gen-2009 | Kordasti, S. Y.; Afzali, B.; Lim, Z.; Ingram, W.; Hayden, J.; Barber, L.; Matthews, K.; Chelliah, R.; Guinn, B.; Lombardi, G.; Farzaneh, F.; Mufti, G. J. | |
| Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group | 1-gen-2012 | Westers, T. M.; Ireland, R.; Kern, W.; Alhan, C.; Balleisen, J. S.; Bettelheim, P.; Burbury, K.; Cullen, M.; Cutler, J. A.; Della Porta, M. G.; Drager, A. M.; Feuillard, J.; Font, P.; Germing, U.; Haase, D.; Johansson, U.; Kordasti, S.; Loken, M. R.; Malcovati, L.; Te Marvelde, J. G.; Matarraz, S.; Milne, T.; Moshaver, B.; Mufti, G. J.; Ogata, K.; Orfao, A.; Porwit, A.; Psarra, K.; Richards, S. J.; Subira, D.; Tindell, V.; Vallespi, T.; Valent, P.; Van Der Velden, V. H. J.; De Witte, T. M.; Wells, D. A.; Zettl, F.; Bene, M. C.; Van De Loosdrecht, A. A. | |
| Neoantigens in MDS Are Associated with Two Novel CD4+T Cell Subsets and Improved Overall Survival | 1-gen-2017 | Coats, T; Smith, Ae; Mourikis, A; Shahin, T; Kulasekararaj, Ag; Best, S; Chitre, S; Ellis, R; Petrov, N; Heck, S; Irish, Jm; Kordasti, S; Mufti, G | |
| Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome | 1-gen-2016 | Kittang, A. O.; Kordasti, S.; Sand, K. E.; Costantini, B.; Kramer, A. M.; Perezabellan, P.; Seidl, T.; Rye, K. P.; Hagen, K. M.; Kulasekararaj, A.; Bruserud, O.; Mufti, G. J. | |
| Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation | 1-gen-2016 | Ceesay, M. M.; Kordasti, S.; Rufaie, E.; Lea, N.; Smith, M.; Wade, J.; Douiri, A.; Mufti, G. J.; Pagliuca, A. | |
| Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation | 1-gen-2013 | Afzali, B.; Edozie, F. C.; Fazekasova, H.; Scotta, C.; Mitchell, P. J.; Canavan, J. B.; Kordasti, S. Y.; Chana, P. S.; Ellis, R.; Lord, G. M.; John, S.; Hilton, R.; Lechler, R. I.; Lombardi, G. | |
| CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) | 1-gen-2007 | Kordasti, S. Y.; Ingram, W.; Hayden, J.; Darling, D.; Barber, L.; Afzali, B.; Lombardi, G.; Wlodarski, M. W.; Maciejewski, J. P.; Farzaneh, F.; Mufti, G. J. | |
| Dendritic cells in myelodysplastic syndromes: From pathogenesis to immunotherapy | 1-gen-2013 | Kerkhoff, N.; Bontkes, H. J.; Westers, T. M.; De Gruijl, T. D.; Kordasti, S.; Van De Loosdrecht, A. A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista37560
- 4 Contributo in Atti di Convegno ...1
Data di pubblicazione
- In corso di stampa25
- 2020 - 20248500
- 2010 - 201914100
- 2000 - 20098817
- 1990 - 19994467
- 1980 - 19891429
- 1970 - 1979213
- 1967 - 196910
Editore
- Elsevier BV:PO Box 211, 1000 AE A...309
- Elsevier Science Limited:Oxford F...237
- Springer Verlag Germany:Tiergarte...155
- Lippincott, Williams & Wilkins:53...116
- Elsevier Science Incorporated / N...98
- Taylor & Francis Limited:Rankine ...98
- S Karger AG:Allschwilerstrasse 10...74
- IEEE / Institute of Electrical an...73
- John Wiley & Sons Incorporated:Cu...62
- Kluwer Academic Publishers:Journa...58
Rivista
- PLOS ONE203
- CLINICAL AND EXPERIMENTAL RHEUMAT...182
- LA RADIOLOGIA MEDICA174
- SCIENTIFIC REPORTS151
- ACTA HORTICULTURAE142
- ANTIMICROBIAL AGENTS AND CHEMOTHE...120
- APPLIED SCIENCES115
- DIGESTIVE AND LIVER DISEASE111
- EUROPEAN UROLOGY110
- BOLLETTINO DELLA SOCIETA' ITALIAN...101
Serie
- ISPRS ANNALS OF THE PHOTOGRAMMETR...1
- LECTURE NOTES IN COMPUTER SCIENCE1
- NEUROLOGY1
- QUADERNI DI RICERCA1
Keyword
- Humans2100
- Female1065
- Male1036
- Middle Aged700
- Aged633
- Adult612
- Animals392
- Italy385
- Treatment Outcome308
- COVID-19265
Lingua
- eng27350
- ita3376
- fre69
- spa41
- ger16
- enm10
- und10
- dut5
- por5
- chi4
Accesso al fulltext
- no fulltext35494
- open1586
- partially open358
- reserved92
- mixed28
- restricted3